Glaucoma Research Foundation Web Site

Stanford’s Kuldev Singh, MD Elected to Chair the Glaucoma Research Foundation

Wed, 01 Jul 2009 11:50:34 -0800

Kuldev Singh, MD, MPH, Professor of Ophthalmology and Director of the Glaucoma Service at the Stanford University School of Medicine, began serving today as the new Board Chair of the Glaucoma Research Foundation (GRF). He was elected Chairman at the recent Board of Directors Annual Meeting. GRF is America’s oldest national institution dedicated solely to preventing vision loss from glaucoma.

This is a summary. Visit our site for the full post ».

Preventing Delay to Follow-up for Patients with Glaucoma

Wed, 17 Jun 2009 15:33:21 -0800

In a new report, UK eye care specialists are being urged to review their systems for the diagnosis and management of open-angle glaucoma in order to preserve the vision of glaucoma patients.

This is a summary. Visit our site for the full post ».

Glaucoma Research Foundation Appoints Candler Gibson Director of Development

Wed, 17 Jun 2009 09:12:31 -0800

The Glaucoma Research Foundation is pleased to announce the addition of Candler Gibson as the organization’s new Director of Development. Mr. Gibson brings nearly 20 years of experience in development and fundraising, most recently as Director of Development for the Johns Hopkins Heart and Vascular Institute in Baltimore.

This is a summary. Visit our site for the full post ».

JustAnswer and Glaucoma Research Foundation Help Individuals See the Light in Preventing Blindness

Tue, 16 Jun 2009 10:11:58 -0800

JustAnswer, the website where people go when they need answers from Doctors, Lawyers, Mechanics or other Experts, announced it is partnering with the Glaucoma Research Foundation, as part of Vision Research Month.

This is a summary. Visit our site for the full post ».

Lecture Presents New Perspectives on Asians and Glaucoma

Tue, 02 Jun 2009 15:32:59 -0800

Asians and Glaucoma: A Different Spectrum of the Disease” was the topic for The Terasaki Lecture, presented by Hisako and Paul Terasaki, PhD at The Terasaki Foundation in Los Angeles, CA.

This is a summary. Visit our site for the full post ».

Traveling with Glaucoma Medications

Fri, 01 May 2009 16:41:24 -0800

If you’re going on vacation and traveling by air, there are some considerations to keep in mind. It’s a good idea to keep your medications with you in your carry-on bag, so you will have them with you in case your luggage is lost or delayed. All prescription medications are permitted in carry-on bags, even those in liquid form.

This is a summary. Visit our site for the full post ».

Glaucoma In Asian Populations

Fri, 01 May 2009 15:32:40 -0800

East Asians experience the highest rate of blindness in the world from one of the two most common types of glaucoma. Primary angle closure glaucoma (PACG) is a major cause of world blindness today, and it is expected to become an even more serious problem as the world population and longevity increases.

This is a summary. Visit our site for the full post ».

Your Eyes Are the Windows to Your Health

Fri, 01 May 2009 11:05:51 -0800

A recent study by the National Eye Institute found that more than 11 million Americans have common vision problems such as nearsightedness, farsightedness, astigmatism, and presbyopia. While this number may sound alarming, the good news is that common vision problems can be detected through a comprehensive dilated eye exam and can be corrected.

This is a summary. Visit our site for the full post ».

Diagnostic Tests

Fri, 01 May 2009 07:31:53 -0800

Early detection, through regular and complete eye exams, is the key to protecting your vision from damage caused by glaucoma. It is important to have your eyes examined regularly. Your eyes should be tested: before age 40, every two to...

This is a summary. Visit our site for the full post ».

Eyedrop Tips

Fri, 01 May 2009 04:12:18 -0800

Prescription eye drops for glaucoma help maintain the pressure in your eye at a healthy level and are an important part of the treatment routine for many people. Always check with your doctor if you are having difficulty. Here are some tips that may help if you have been prescribed eye drops for glaucoma treatment.

This is a summary. Visit our site for the full post ».

Charity Navigator Awards GRF Highest Rating

Thu, 23 Apr 2009 12:10:54 -0800

For the third consecutive year, the Glaucoma Research Foundation has been awarded a 4-star rating of "Exceptional” from Charity Navigator, the leading independent charity evaluator in the United States.

This is a summary. Visit our site for the full post ».

Catalyst For a Cure Publications and Abstracts (2008)

Mon, 20 Apr 2009 11:17:47 -0800

In 2008, the Catalyst for a Cure research scientists achieved peer acknowledgement in key science publications.

This is a summary. Visit our site for the full post ».

David Calkins Promoted to Director of Research for the Vanderbilt Eye Institute

Tue, 14 Apr 2009 11:58:30 -0800

Catalyst For a Cure Principal Investigator David J. Calkins, PhD was promoted to Director of Research for the Vanderbilt Eye Institute, effective April 1st. Dr. Calkins has a distinguished background, receiving his PhD at University of Pennsylvania and then doing his postdoctoral work at Johns Hopkins.

This is a summary. Visit our site for the full post ».

American Glaucoma Society Annual Meeting

Fri, 10 Apr 2009 12:35:15 -0800

Thomas M. Brunner, GRF's President and CEO, and Allen B. Poirson, PhD, Director of Scientific Programs and Licensing, attended the American Glaucoma Society meeting in San Diego. Dr. Poirson reports that neuroprotection, neuroregeneration and utilizing molecular and cellular techniques to study and stratify glaucoma are of growing interest to clinical practitioners — indicating that scientific advances on these fronts are accelerating and the Glaucoma Research Foundation can continue to help translate these discoveries into clinical practice.

This is a summary. Visit our site for the full post ».

Spotlight on Research: Catalyst For a Cure Progress Report

Fri, 10 Apr 2009 10:30:03 -0800

In the past year, the Catalyst For a Cure (CFC) made key observations of changes to the visual pathways from the eye to the brain that occur in glaucoma, some of these changes occurring very early in the disease. These findings contain significant implications, whose further study may well lead to new diagnostics or treatment possibilities for glaucoma.

This is a summary. Visit our site for the full post ».